A phase II trial of autologous bone marrow transplantation (ABMT) in acute leukemia with edelfosine purged bone marrow

Advances in Experimental Medicine and Biology

Volumn 416, Issue , 1997, Pages 389-396

  Vogler, William R ^a   Berdel, Wolfgang E ^b   Geller, Robert B ^a   Brochstein, Joel A ^c   Beveridge, Roy A ^d   Dalton, William S ^e   Miller, Kenneth B ^f   Lazarus, Hillard M ^g  

^a EMORY UNIVERSITY   (United States)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^d Fairfax Hematol Oncology Associates   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f TUFTS MEDICAL CENTER   (United States)

^g CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; EDELFOSINE; ETOPOSIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW PURGING; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; SURVIVAL TIME; WHOLE BODY RADIATION;

EID: 0030964102     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (14)

1. Munder PG, Weltzien HU, Modolell M: Lysolecithin analogs: a new class of immunopotentiators. Immunodeficiency and immunostimulation, in Miescher PA (ed): Seventh international symposium on immunopathology, Basel/Stuttgard, Schwabe & Co, 1976, p 411
2. Munder PG, Modolell M, Bausert W, Oettgen HF, Westphal O: alkyllysophospholipids in cancer therapy, in Hersh EM (ed): Augmenting agents in cancer therapy, New York, Raven Press, 1981, p 441
3. Andreesen R, Modolell M, Weltzien HU, Eibl H, Common HH, Lohr GW, Munder PG: Selective destruction of human leukemic cells by alkyl-lysophospholipids. Cancer Res 38:3894, 1978
4. Modelell M, Andreesen R, Pahlke W, Brugger U, Munder PG: Disturbance of phospholipid metabolism by the selective destruction of tumor cells by alkyl-lysophospholipids. Cancer Res 39:4681, 1979
5. Andreesen R, Modollel M, Munder PG: Selective sensitivity of chronic myelogenous leukemic cell populations to alkyl-lysophospholipids. Blood 54:519, 1979
6. Vogler WR, Whigham EA, Somberg LB, Long RC, Winton EF: The effect of alkyl-lysophospholipids on tritiated thymidine incorporation and clonogenicity in vitro of normal and leukemic human cells. Exp Hematol 12:569, 1984
7. Verdonck LF, Witteveen EO, van Heugten HG, Rozemuller E, Rijksen G: Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid. Cancer Res 50:4020, 1990
8. Dulisch I, Neumann HA, Lohr GW, Andreesen R: Clonogenicity of normal and malignant hematopoietic progenitor cells after exposure to alkyl-lysophospholipids. Blut 51:393, 1985
9. Okamoto S, Olson AC, Vogler WR, Winton EF: Purging leukemic cells from simulated remission marrow with alkyl-lysophospholipids. Blood 69:1381, 1987
10. Glasser L, Somberg LB, Vogler WR: Purging murine leukemic marrow with alkyl-lysophospholipids. Blood 64:1288, 1984
11. Vogler WR, Somberg LB, Glasser L: Effect of cryopreservation on purging of leukemic marrow with alkyl-lysophospholipids. Exp Hematol 15:360, 1987
12. Vogler WR, Berdel WE, Olson AC, Winton EF, Heffner LT, Gordon DS: Autologous bone marrow transplantation in acute leukemia with marrow purged with alkyl-lysophospholipid. Blood 80:1423, 1992
13. Gorin NC, Aegerter P, Auvert B, Meloni B, Goldstone AH, Burnett A, Carella A, Korbling M, Herve P, Maraninchi D, Lowenberg R, Verdonck LF, de Planque M, Hermans J, Helbig W, Porcellini A, Rizzoli V, Alesandrino EP, Franklin IM, Reiffers J, Colleselli P, Goldman JM: Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. Blood 75:1606, 1990
14. Laporte JP, Douay L, Lopez M, Labopin M, Jouet JP, Lesage S, Stachowiak L, Fouillard L, Isnard F, Noel-Walter MP, Pene F, Deloux J, Van Dan Akker J, Bauters F, Najman A, Gorin NC: One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged by mafosfamide: a 10-year single institution experience. Blood 84:3810, 1994